412 related articles for article (PubMed ID: 26699403)
1. Regulation of Histone Acetylation by Autophagy in Parkinson Disease.
Park G; Tan J; Garcia G; Kang Y; Salvesen G; Zhang Z
J Biol Chem; 2016 Feb; 291(7):3531-40. PubMed ID: 26699403
[TBL] [Abstract][Full Text] [Related]
2. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
Harrison IF; Smith AD; Dexter DT
Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
[TBL] [Abstract][Full Text] [Related]
3. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG
J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743
[TBL] [Abstract][Full Text] [Related]
4. Manganese chloride induces histone acetylation changes in neuronal cells: Its role in manganese-induced damage.
Guo Z; Zhang Z; Wang Q; Zhang J; Wang L; Zhang Q; Li H; Wu S
Neurotoxicology; 2018 Mar; 65():255-263. PubMed ID: 29155171
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
6. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.
Yakhine-Diop SMS; Niso-Santano M; Rodríguez-Arribas M; Gómez-Sánchez R; Martínez-Chacón G; Uribe-Carretero E; Navarro-García JA; Ruiz-Hurtado G; Aiastui A; Cooper JM; López de Munaín A; Bravo-San Pedro JM; González-Polo RA; Fuentes JM
Mol Neurobiol; 2019 Apr; 56(4):2466-2481. PubMed ID: 30032424
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
Wang R; Sun H; Wang G; Ren H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
[TBL] [Abstract][Full Text] [Related]
8. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
9. Targeting histone acetylation for neuroprotection.
Contestabile A
Curr Pharm Des; 2013; 19(28):5017-8. PubMed ID: 23448467
[No Abstract] [Full Text] [Related]
10. Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum).
Kirfel P; Skaljac M; Grotmann J; Kessel T; Seip M; Michaelis K; Vilcinskas A
Arch Insect Biochem Physiol; 2020 Mar; 103(3):e21614. PubMed ID: 31498475
[TBL] [Abstract][Full Text] [Related]
11. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
12. Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration.
Song C; Kanthasamy A; Jin H; Anantharam V; Kanthasamy AG
Neurotoxicology; 2011 Oct; 32(5):586-95. PubMed ID: 21777615
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).
Kadiyala CS; Zheng L; Du Y; Yohannes E; Kao HY; Miyagi M; Kern TS
J Biol Chem; 2012 Jul; 287(31):25869-80. PubMed ID: 22648458
[TBL] [Abstract][Full Text] [Related]
14. LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Mazzocchi M; Goulding SR; Wyatt SL; Collins LM; Sullivan AM; O'Keeffe GW
Mol Cell Neurosci; 2021 Sep; 115():103642. PubMed ID: 34119632
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes.
Wang Z; Zang C; Cui K; Schones DE; Barski A; Peng W; Zhao K
Cell; 2009 Sep; 138(5):1019-31. PubMed ID: 19698979
[TBL] [Abstract][Full Text] [Related]
17. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
[TBL] [Abstract][Full Text] [Related]
18. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
Roccaro AM; Sacco A; Jia X; Azab AK; Maiso P; Ngo HT; Azab F; Runnels J; Quang P; Ghobrial IM
Blood; 2010 Sep; 116(9):1506-14. PubMed ID: 20519629
[TBL] [Abstract][Full Text] [Related]
19. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.
Fass DM; Reis SA; Ghosh B; Hennig KM; Joseph NF; Zhao WN; Nieland TJ; Guan JS; Kuhnle CE; Tang W; Barker DD; Mazitschek R; Schreiber SL; Tsai LH; Haggarty SJ
Neuropharmacology; 2013 Jan; 64():81-96. PubMed ID: 22771460
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
